Chimeric hepatitis E virus-like particle as a carrier for oral-delivery

Vaccine

Volumn 31, Issue 2, 2013, Pages 417-424

  Jariyapong, Pitchanee ^a,b   Xing, Li ^a   van Houten, Nienke E ^c   Li, Tian Cheng ^d   Weerachatyanukul, Wattana ^a,b   Hsieh, Benjamin ^a   Moscoso, Carlos G ^a   Chen, Chun Chieh ^a   Niikura, Masahiro ^c   Cheng, Holland ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Mahidol University   (Thailand)

^c SIMON FRASER UNIVERSITY   (Canada)

^d NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

Hepatitis E virus; HIV 1 epitope; Quaternary structure; Recombinant capsid protein; Trypsin proteolysis; Virus like particle

Indexed keywords

BACULOVIRUS VECTOR; GLYCOPROTEIN GP 120; MEMBRANE ANTIGEN; RECOMBINANT PROTEIN; TRYPSIN;

ANTIBODY COMBINING SITE; ARTICLE; BACULOVIRUS; CHIMERA; CYTOTOXIC T LYMPHOCYTE; DRUG DELIVERY SYSTEM; ELECTRON MICROSCOPY; HEPATITIS E; HEPATITIS E VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMORAL IMMUNITY; HYDROPHOBICITY; IMMUNOREACTIVITY; MOLECULAR WEIGHT; MUTATIONAL ANALYSIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; STRUCTURE ACTIVITY RELATION; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS LIKE AGENT; WILD TYPE;

ADMINISTRATION, ORAL; AMINO ACID SEQUENCE; ANTIGENS, VIRAL; BINDING SITES; CAPSID PROTEINS; HEPATITIS ANTIBODIES; HEPATITIS E VIRUS; HIV ENVELOPE PROTEIN GP120; MOLECULAR SEQUENCE DATA; RECOMBINANT FUSION PROTEINS; VACCINES;

EID: 84871376730     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.10.073     Document Type: Article

References (35)

1. Holmgren J., Czerkinsky C. Mucosal immunity and vaccines. Nat Med 2005, 11:S45-S53.
2. Ogra P.L., Faden H., Welliver R.C. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001, 14:430-445.
3. Ludwig C., Wagner R. Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol 2007, 18:537-545.
4. Uchida M., Klem M.T., Allen M., Suci P., Flenniken M., Gillitzer E., et al. Biological containers: protein cages as multifunctional nanoplatforms. Adv Mater 2007, 19:1025-1042.
5. Clark B., Caparros-Wanderley W., Musselwhite G., Kotecha M., Griffin B.E. Immunity against both polyomavirus VP1 and a transgene product induced following intranasal delivery of VP1 pseudocapsid-DNA complexes. J Gen Virol 2001, 82:2791-2797.
6. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome. Virology 1991 Nov, 185(1):120-131.
7. Emerson S., Purcell R. Hepatitis E virus. Fields Virology 2007, 3047-3058. Lippincott Willimas & Wilkins, Philadelphia. Fifth ed. D.M. Knipe, P.M. Howley (Eds.).
8. Li T.-C., Takeda N., Miyamura T., Matsuura Y., Wang J.C.Y., Engvall H., et al. Essential elements of the capsid protein for self-assembly into empty virus-like particles of hepatitis E virus. J Virol 2005, 79(October (20)):12999-13006.
9. Xing L., Kato K., Li T., Takeda N., Miyamura T., Hammar L., et al. Recombinant hepatitis E capsid protein self-assembles into a dual-domain T=1 particle presenting native virus epitopes. Virology 1999, 265(December (1)):35-45.
10. Li T.C., Yamakawa Y., Suzuki K., Tatsumi M., Razak M.A., Uchida T., et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997, 71(October (10)):7207-7213.
11. Takamura S., Niikura M., Li T.C., Takeda N., Kusagawa S., Takebe Y., et al. DNA vaccine-encapsulated virus-like particles derived from an orally transmissible virus stimulate mucosal and systemic immune responses by oral administration. Gene Ther 2004, 11(April (7)):628-635.
12. Niikura M., Takamura S., Kim G., Kawai S., Saijo M., Morikawa S., et al. Chimeric recombinant hepatitis E virus-like particles as an oral vaccine vehicle presenting foreign epitopes. Virology 2002, 293(February (2)):273-280.
13. Li T., Takeda N., Miyamura T. Oral administration of hepatitis E virus-like particles induces a systemic and mucosal immune response in mice. Vaccine 2001, 19(May (25-26)):3476-3484.
14. Xing L., Li T.C., Miyazaki N., Simon M.N., Wall J.S., Moore M., et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 2010, 285:33175-33183.
15. Guu T., Liu Z., Ye Q., Mata D., Li K., Yin C., et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci U S A 2009, 106:12992-12997.
16. Yamashita T., Mori Y., Miyazaki N., Cheng H., Yoshimura M., Unno H., et al. Biological and immunological characterics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci U S A 2009, 106:12986-12991.
17. Schofield D.J., Purcell R.H., Nguyen H.T., Emerson S.U. Monoclonal antibodies that neutralize HEV recognize an antigenic site at the carboxyterminus of an ORF2 protein vaccine. Vaccine 2003, 22(December (2)):257-267.
18. Zhang J., Gu Y., Ge S.X., Li S., He Z., Huang G., et al. Analysis of hepatitis E neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine 2005, 23:2881-2892.
19. Li X., Zafrullah M., Ahmad F., Jameel S. A C-terminal hydrophobic region is required for homo-oligomerization of the hepatitis E virus capsid (ORF2) protein. J Biomed Biotechnol 2001, 1(3):122-128.
20. Li S., Tang S., Seetharaman J., Yang C.Y., Gu Y., Zhang J., et al. Dimerization of hepatitis E virus capsid protein E2s domain is essential for virus-host interaction. PLos Pathog 2009, 5(8):e1000537.
21. Yu H., Li S., Yang C.Y., Wei M., Song C., Zheng Z., et al. Homology model and potential virus-capsid binding site of a putative HEV receptor Grp78. J Mol Model 2010, [Epub ahead of print].
22. Xing L., Wang J.C., Li T.C., Yasutomi Y., Lara J., Khudyakov Y., et al. Spatial configuration of hepatitis E virus antigenic domain. J Virol 2011, 85(January (2)):1117-1124.
23. Takahashi H., Cohen J., Hosmalin A., Cease K.B., Houghten R., Cornette J.L., et al. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine ctyotoxic T lymphocytes. Proc Natl Acad Sci U S A 1988, 85:3105-3109.
24. Zhou Y.H., Purcell R., Emerson S. A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus. Vaccine 2005, 23:3157-3165.
25. Kyd J.M., Cripps A. Functional differences between M cells and enterocytes in sampling luminal antigens. Vaccine 2008, 26:6221-6224.
26. Gullberg E., Keita A.V., Salim S.Y., Andersson M., Caldwell K.D., Söderholm J.D., et al. Identification of cell adhesion molecules in the human follicle-associated epithelium that improves nanoparticle uptake into the Peyer's patches. J Pharmacol Exp Ther 2006, 319(2):632-639.
27. Clark M., Hirst B.H., Jepson M. M-cell surface b1 integrin expression and invasin-mediated targetting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells. Infect Immun 1998, 66:1237-1243.
28. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Dev Biol 1996, 12:697-715.
29. Baker T.S., Cheng R.H. A model-based approach for determining orientations of biological macromolecules imaged by cryoelectron microscopy. J Struct Biol 1996, 116(January-February (1)):120-130.
30. Baker T.S., Cheng R.H. A model-based approach for determining orientations of biological macromolecules imaged by cryoelectron microscopy. J Struct Biol 1996, 116(1):120-130.
31. Jones T.A., Zou J.Y., Cowan S.W., Kjeldgaard M. Improved method for building protein model in electron density maps and the location of errors in these models. Acta Crystallogr Sect A 1991, 47:110-119.
32. Wriggers W. Using situs for the integration of multi-resolution structures. Biophys Rev 2010, 2:21-27.
33. Xing L., Li T.C., Mayazaki N., Simon M.N., Wall J.S., Moore M., et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 2010, 285(43):33175-33183.
34. Xing L., Wang J.C., Li T.-C., Yasutomi Y., Lara J., Khudyakov Y., et al. Spatial configuration of hepatitis E virus antigenic domain. J Virol 2011, 85:1117-1124.
35. DeLano W.L. The PYMOL molecular graphics system 2002, DeLano Scientific, Palo Alto, CA, USA.